189 related articles for article (PubMed ID: 36156373)
1. Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics.
Vita NA; Anderson SM; LaFleur MD; Lee RE
Curr Opin Microbiol; 2022 Dec; 70():102203. PubMed ID: 36156373
[TBL] [Abstract][Full Text] [Related]
2. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Resistance of
Hasanuzzaman M; Bang CS; Gong EJ
J Korean Med Sci; 2024 Jan; 39(4):e44. PubMed ID: 38288543
[No Abstract] [Full Text] [Related]
4. Antibiotic therapy for Helicobacter pylori.
Collins J; Ali-Ibrahim A; Smoot DT
Med Clin North Am; 2006 Nov; 90(6):1125-40. PubMed ID: 17116440
[TBL] [Abstract][Full Text] [Related]
5. [RESISTANCE OF HELICOBACTER PYLORI TO ANTIBIOTICS IN ISRAEL: PAST VS PRESENT].
Peretz A; Paritsky M; Brodsky D; Pastukh N; On A
Harefuah; 2017 Oct; 156(10):642-644. PubMed ID: 29072383
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori antibiotic resistance: trends over time.
Lahaie RG; Gaudreau C
Can J Gastroenterol; 2000 Nov; 14(10):895-9. PubMed ID: 11188800
[TBL] [Abstract][Full Text] [Related]
7. Identification of Antimotilins, Novel Inhibitors of Helicobacter pylori Flagellar Motility That Inhibit Stomach Colonization in a Mouse Model.
Suerbaum S; Coombs N; Patel L; Pscheniza D; Rox K; Falk C; Gruber AD; Kershaw O; Chhatwal P; Brönstrup M; Bilitewski U; Josenhans C
mBio; 2022 Apr; 13(2):e0375521. PubMed ID: 35227071
[TBL] [Abstract][Full Text] [Related]
8. Eradication of
Zhang Q; Wu W; Zhang J; Xia X
Nanomedicine (Lond); 2020 Feb; 15(5):527-542. PubMed ID: 32028847
[No Abstract] [Full Text] [Related]
9. Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.
Kouitcheu Mabeku LB; Eyoum Bille B; Tepap Zemnou C; Tali Nguefack LD; Leundji H
BMC Infect Dis; 2019 Oct; 19(1):880. PubMed ID: 31640588
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam.
Phan TN; Tran VH; Tran TN; Le VA; Santona A; Rubino S; Paglietti B
J Infect Dev Ctries; 2015 Jul; 9(6):609-13. PubMed ID: 26142670
[TBL] [Abstract][Full Text] [Related]
11. Gastric infection by Helicobacter pylori.
Sachs G; Scott DR; Wen Y
Curr Gastroenterol Rep; 2011 Dec; 13(6):540-6. PubMed ID: 21993716
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori
Luo P; Huang Y; Hang X; Tong Q; Zeng L; Jia J; Zhang G; Bi H
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318002
[No Abstract] [Full Text] [Related]
13. Analysis of the Primary and Post-Treatment Antibiotic Resistance of Helicobacter pylori in the Nanjing Area.
Jiang ZD; He BS; Zhang ZY; Wang SK; Ran D; Wang ZB
Curr Pharm Biotechnol; 2021; 22(5):682-685. PubMed ID: 32811409
[TBL] [Abstract][Full Text] [Related]
14. Strategies to treat patients with antibiotic resistant Helicobacter pylori.
Mégraud F
Int J Antimicrob Agents; 2000 Dec; 16(4):507-9. PubMed ID: 11118869
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem.
Hu Y; Zhang M; Lu B; Dai J
Helicobacter; 2016 Oct; 21(5):349-63. PubMed ID: 26822340
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin for Helicobacter pylori infection.
Leung WK; Graham DY
Expert Opin Pharmacother; 2000 Mar; 1(3):507-14. PubMed ID: 11249534
[TBL] [Abstract][Full Text] [Related]
17. Future Nanotechnology-Based Strategies for Improved Management of Helicobacter pylori Infection.
Kamankesh M; Yadegar A; Llopis-Lorente A; Liu C; Haririan I; Aghdaei HA; Shokrgozar MA; Zali MR; Miri AH; Rad-Malekshahi M; Hamblin MR; Wacker MG
Small; 2024 Jan; 20(3):e2302532. PubMed ID: 37697021
[TBL] [Abstract][Full Text] [Related]
18. Review of current diagnostic methods and advances in
Pohl D; Keller PM; Bordier V; Wagner K
World J Gastroenterol; 2019 Aug; 25(32):4629-4660. PubMed ID: 31528091
[No Abstract] [Full Text] [Related]
19. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications.
Gerrits MM; van Vliet AH; Kuipers EJ; Kusters JG
Lancet Infect Dis; 2006 Nov; 6(11):699-709. PubMed ID: 17067919
[TBL] [Abstract][Full Text] [Related]
20. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
